CIK: 1178579 - Address: 4747 Executive Dr, Suite 210, San Diego, CA 92121
11 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
8/5/25 17:31
8/1/25
AUPHAurinia Pharmaceuticals Inc.HealthDrugPharmaceutical PreparationsTang KevinCADP.m13,59010.4501,3001311,330I
3/4/25 17:03
2/28/25
AUPHAurinia Pharmaceuticals Inc.HealthDrugPharmaceutical PreparationsTang KevinCADP.m12,7137.9501,6001910,030I
12/9/24 16:52
12/5/24
AUPHAurinia Pharmaceuticals Inc.HealthDrugPharmaceutical PreparationsTang KevinCADP.m10,8229.0201,200178,430I
9/18/24 16:31
9/16/24
OMICSingular Genomics Systems, Inc.DEElectrLabEqLaboratory Analytical InstrumTang KevinCATP.m1,80614.75012249372I
10/13/23 16:57
10/11/23
RAINRain Oncology Inc.DEHealthDrugPharmaceutical PreparationsTang Kevin CCATP.m2790.9820028484,024I
6/1/23 18:46
5/30/23
RAINRain Oncology Inc.DEHealthDrugPharmaceutical PreparationsTang Kevin CCATP.m1,1591.0601,088413,740I
5/30/23 20:02
5/25/23
TCRRTcr2 Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagTang Kevin CCATP861.7205014,395I
5/15/23 17:12
5/11/23
TCRRTcr2 Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagTang Kevin CCATP.m881.9504514,345I
5/10/23 19:02
5/8/23
TCRRTcr2 Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagTang Kevin CCATP.m1641.9508424,300I
5/5/23 18:52
5/3/23
TCRRTcr2 Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagTang Kevin CCATP.m5481.89029074,216I
3/14/23 20:39
3/13/23
JNCEJounce Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagTang Kevin CCATP.m860.999708625,300I

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact